Lack of interferon consensus sequence binding protein (ICSBP) transcripts in human myeloid leukemias

Blood

Volumn 91, Issue 1, 1998, Pages 22-29

  Schmidt, Manuel ^b   Nagel, Stefan ^b   Probe, Jutta ^b   Thiede, Christian ^b   Ritter, Markus ^b   Waring, Jeffrey F ^b   Rosenbauer, Frank ^b   Huhn, Dieter ^b   Wittig, Burghardt ^b   Horak, Ivan ^b   Neubauer, Andreas ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERFERON; INTERFERON CONSENSUS SEQUENCE BINDING PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; B LYMPHOCYTE; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DNA BINDING; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE INDUCTION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; LEUKEMOGENESIS; MYELOID LEUKEMIA; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

EID: 0031964844     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.1.22     Document Type: Article

References (33)

1. Petska S, Langer JA, Zoon KC, Samuel CE: Interferons and their actions. Annu Rev Biochem 56:727, 1987
2. Williams BRG: Transcriptional regulation of interferon-stimulated genes. Eur J Biochem 200:1, 1991
3. Tanaka N, Taniguchi T: Cytokine gene regulation: Regulatory cis elements and DNA binding factors involved in the interferon system. Adv Immunol 52:263, 1992
4. Daggers PH, Ennist DL, Gleason SL, Mak W-H, Marks MS, Levi B-Z Flanagan JR, Appella E, Ozato K: An interferon γ-regulated protein that binds the interferon-inducible enhancer-element of major histocompatibility complex class I genes. Proc Natl Acad Sci USA 87:3743, 1990
5. Weisz A, Marx P, Sharf R, Appella E, Driggers PH, Ozato K, Levi B-Z: Human interferon consensus sequence binding protein is a negative regulator of enhancer elements common to interferon-inducible genes. J Biol Chem 267:25589, 1992
6. Miyamoto M, Fujita T, Kimura Y, Maruyama M, Harada H, Sudo Y, Miyata T, Taniguchi T: Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-β gene regulatory elements. Cell 54:903, 1988
7. Harada H, Fujita T, Miyamoto M, Kimura Y, Maruyama M, Furia A, Miyata T, Taniguchi T: Structurally similar but functionally distinct factors. IRF1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes. Cell 58:729, 1989
8. Au W-C, Moore PA, Lowther W, Juang Y-T, Pitha PM: Identification of a member of the interferon regulatory factor family that binds to the interferon-stimulated response element and activates expression of interferon-induced genes. Proc Natl Acad Sci USA 92:11657, 1995
9. Veals SA, Schindler C, Leonard D, Fu X-Y, Aebersold R, Darnell JE Jr, Levy DE: Subunit of an alpha-interferon-responsive transcription factor is related to interferon regulatory factor and Myb families of DNA-binding proteins. Mol Cell Biol 12:3315, 1992
10. Yamagata T, Nishida J, Tanaka T, Sakai R, Mitani K, Yoshida M, Taniguchi T, Yazaki Y, Hirai H: A novel interferon regulatory factor family transcription factor, ICSAT/Pip/LSIRF, that negatively regulates the activity of interferon-regulated genes. Mol Cell Biol 16:1283, 1996
11. Nelson N, Kanno Y, Hong C, Contursi C, Fujita T, Fowlkes BJ, O'Connel E, Hu-Li J, Paul WE, Jankovic D, Sher AF, Coligan JE, Thornton A, Appella E, Yang Y, Ozato K: Expression of interferon regulatory factor family proteins in lymphocytes. Induction of Stat 1 and ICSBP expression by T cell activation. J Immunol 156:3711, 1996
12. Matsuyama T, Kimura T, Kitagawa M, Pfeffer K, Kawakami T, Watanabe N, Kündig TM, Amakawa R, Kishihara K, Wakeham A, Potter J, Furlonger CL, Naredran A, Suzuki H, Ohashi PS, Paige CJ, Taniguchi T, Mak TW: Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development. Cell 75:83, 1993
13. Willman CL, Sever CE, Pallavicini MG, Harada H, Tanaka N, Slovak ML, Yamamoto H, Harada K, Meeker TC, List AF, Taniguchi T: Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia. Science 259:968, 1993
14. Nagarajan L, Zavadie J, Claxton D, Lu X, Fairman J, Warrington JA, Wasmuth JJ: Consistent loss of the D5S89 locus mapping telomeric to the interleukin gene cluster and centromeric to EGR-1 in patients with 5q (-) chromosome. Blood 83:199, 1994
15. Fischer T, Aman J, van der Kuip H, Rudolf G, Peschel C, Aulitzky WE, Huber C: Induction of interferon regulatory factors, 2′-5′ oligoadenylate synthetase, P68 kinase and RNase L in chronic myelogenous leukemia cells and its relationship to clinical responsiveness. Br J Haematol 92:595, 1996
16. Holtschke T, Löhler J, Kanno Y, Fehr T, Giese N, Rosenbauer F, Lou J, Knobeloch K-P, Gabriele L, Waring JF, Bachmann MF, Zinkernagel RM, Morse HC III, Ozato K, Horak I: Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene. Cell 87:307, 1996
17. Nowell PC, Hungerford DA: A minute chromosome in human chronic granulocytic leukemia. Science 132:1497, 1960
18. Rowley JD: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa banding. Nature 243:290, 1973
19. Seelig R, Schranz P, Bottner C, Neubauer A, Seelig HP, Renz M: The chronic myelocytic cell line K 562 contains minor (m) as well as major (M) bcr/abl fusion mRNAs. Leukemia 7:1886, 1993
20. Nagel S, Schmidt M, Thiede C, Huhn D, Neubauer A: Quantification of Bcr-Abl transcripts in chronic myelogenous leukemia (CML) using standardized, internally controlled, competitive differential PCR (CD-PCR). Nucleic Acids Res 24:4102, 1996
21. Talpaz M, Kantarjian HM, McCredie K, Truillo JM, Kearing MJ, Gutterraan JU: Hematologic remission and cytogenetic improvement induced by recombinant human interferon alpha(A) in chronic myelogenous leukemia. N Engl J Med 314:1065, 1986
22. Tura S, Baccarani M, Zuffa E, Russo D, Fanin R, Zaccaria A, Fiacchim M: Interferon alfa-2a as compared with conventional chemotherapy for the treatment of chronic myeloid leukemia. N Engl J Med 330:820, 1994
23. Allan NC, Richards SM, Shepherd PCA: UK Medical Research Council randomized multicentre trial of interferon-alpha n1 for chronic myeloid leukemia: Improved survival irrespective of cytogenetic response. Lancet 345:1392, 1995
24. Talpaz M, Chernajovsky Y, Troutman-Worden K, Wetzler M, Kantarjian H, Gutterman JU, Kurzrock R: Interferon-stimulated genes in interferon-sensitive and resistant chronic myelogenous leukemia patients. Cancer Res 52:1087, 1992
25. Otterson GA, Khleif SN, Chen W, Coxon AB, Kaye FJ: CDKN2 gene silencing in lung cancer by DNA hypermethylation and kinetics of p16INK4 protein induction by 5-aza 2′deoxycytidine. Oncogene 11: 1211, 1995
26. Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB, Sidrausky D: 5′ CpG island methylation is associated with transcriptional silencing of the tumor suppressor p16/CDKN2/MTS1 in human cancers. Nat Med 1:686, 1995
27. Kurzrock R, Talpaz M, Kantarjian H, Walters R, Saks S, Trujillo JM, Gutterman JU: Therapy of chronic myelogenous leukemia with recombinant interferon-γ. Blood 70:943, 1987
28. Kloke O, May D, Wandl U, Becher R, Opalka B, Beer U, Niederle N: Treatment of chronic myelogenous leukemia with interferons alpha and gamma. Blut 61:45, 1990
29. Russo D, Fanin R, Zuffa E, Damiani D, Gallizia C, Michieli M, Testoni N, Benfenati D, Visani G, Zaccaria A, Baccarani M, Tura S: Sequential treatment of Ph-positive chronic myeloid leukemia with interferon gamma and interferon alpha. Haematologica 75:334, 1990
30. Opalka B, Wandl UB, Becher R, Kloke O, Nagel-Hiemke M, Moritz T, Beer U, Seeber S, Niederle N: Minimal residual disease in patients with chronic myelogenous leukemia undergoing long-term treatment with recombinant interferon alpha-2b alone or in combination with interferon gamma. Blood 78:2188, 1991
31. Bhatia R, Wayner EA, McGlave PB, Verfaillie CM: Interferon-alpha restores normal adhesion of chronic myelogenous leukemia hematopoietic progenitors to bone marrow stroma by correcting impaired beta 1 integrin receptor function. J Clin Invest 94:384, 1994
32. Aman MJ, Rudolf G, Goldschmitt J, Aulitzky WE, Lam C, Huber C, Peschel C: Type-I interferons are potent inhibitors of interleukin-8 production in hematopoietic and bone marrow stromal cells. Blood 82:2371, 1993
33. Aman MJ, Keller U, Derigs G, Mohamadzadeh M, Huber C, Peschel C: Regulation of cytokine expression by interferon-alpha in human bone marrow stromal cells: Inhibition of hematopoietic growth factors and induction of interleukin-1 receptor antagonist. Blood 84:4142, 1994